|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project. Thromb Haemost. 2017 Oct 5;117(10):1848-1858. doi: 10.1160/TH17-07-0478. Epub 2017 Aug 11. PubMed PMID: 28799620.
AÑO: 2017; IF: 4.952
|
28799620
|
Orenes-Piñero E, Esteve-Pastor MA, Valdés M, Lip GYH, Marín F. Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation. Drug Discov Today. 2017 Oct;22(10):1565-1571. doi: 10.1016/j.drudis.2017.05.010. Epub 2017 Jul 8. Review. PubMed PMID: 28692826.
AÑO: 2017; IF: 6.848
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA(2)DS(2)-VASc Scores. J Am Heart Assoc. 2017 Jul 20;6(7). pii: e006490. doi: 10.1161/JAHA.117.006490. PubMed PMID: 28729407; PubMed Central PMCID: PMC5586327.
AÑO: 2017; IF: 4.45
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Lip GYH. Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks. Am J Hypertens. 2017 Nov 1;30(11):1063-1065. doi: 10.1093/ajh/hpx135. PubMed PMID: 28985289.
AÑO: 2017; IF: 3.046
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost. 2017 Jun 27;117(7):1448-1454. doi: 10.1160/TH16-12-0961. Epub 2017 Mar 23. PubMed PMID: 28331926.
AÑO: 2017; IF: 6.681
|